UNSPSC 51161883: Tetrahydrozoline

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier S9U025Y077, chemically known as 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazole but more generally known as tetrahydrozoline, which bears U.S. National Institutes of Health Compound Identifier 5419. The European Medicines Agency schedules Tetryzoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10955MIG.

The term TETRYZOLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). The World Health Organization schedules tetrahydrozoline in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C1CC(C2=CC=CC=C2C1)C3=NCCN3.

UNSPSC 51161883 Tetrahydrozoline (Commodity) encompasses pharmaceutical products and medical supplies that state and local governments procure for health and correctional services. Based on recent solicitations, the code reflects demand for specialized pharmaceutical products including tetrahydrozoline and related parenteral pharmaceuticals, intravenous solutions, naloxone, and drug deactivation systems. State and local issuing bodies—particularly state departments of corrections, county health departments, and community health agencies—solicit these products to support medically necessary healthcare for incarcerated populations, emergency response, and public health initiatives. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body mix, with procurement offices managing supply contracts that require demonstrated experience in pharmaceutical preparation, rapid delivery capability, appropriate licensure, and compliance with state-specific regulations and insurance requirements.

Recent activity shows Washington state and Florida leading current solicitation volume. The Washington State Department of Corrections posted RFQ RFQQK13020 on September 8, 2026, due October 7, 2026, soliciting parenteral products, services, and equipment for eight correctional facilities across three regions, with multiple awards anticipated and contract pricing fixed through November 2028. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries and an initial two-year term plus one-year renewal option. Both solicitations require vendors to hold appropriate state licensure, clear background checks, maintain specified insurance coverage, and meet rapid delivery timelines—parenteral nutrition bags within 24 hours in Washington and overall delivery within 8 hours for first-supply quantities. Set-aside programs appear in the Washington solicitation, with aspirational goals for small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation.